Event Videos

https://www.ncbi.nlm.nih.gov/pubmed/29570556

J Pediatr Gastroenterol Nutr. 2018 Mar 22. doi: 10.1097/MPG.0000000000001950. [Epub ahead of print]

Province-Wide Biliary Atresia Home Screening Program in British Columbia: Evaluation of First Two Years. Woolfson JP, Schreiber RA, Butler AE, MacFarlane J, Kaczorowski J, Masucci L, Bryan S, Collet JP.

Abstract

BACKGROUND:

Published on: 
Mar-2018

https://www.ncbi.nlm.nih.gov/pubmed/29570559

J Pediatr Gastroenterol Nutr. 2018 Mar 22. doi: 10.1097/MPG.0000000000001965. [Epub ahead of print]

The Health Care Transition of Youth With Liver Disease into the Adult Health System: Position Paper from ESPGHAN and EASL.

Vajro P, Fischler B, Burra P, Debray D, Dezsofi A, Guercio Nuzio S, Hadzic N, Hierro L, Jahnel J, Lamireau T, McKiernan P, McLin V, Nobili V, Socha P, Smets F, Baumann U, Verkade HJ.

Abstract

BACKGROUND:
Medical advances have dramatically improved the long-term prognosis of children and adolescents with once-fatal hepatobiliary diseases. However, there is no generally accepted optimal pathway of care for the transition from paediatric care to the adult health system.

AIM:

Published on: 
Mar-2018

https://www.ncbi.nlm.nih.gov/pubmed/29601439

J Pediatr Gastroenterol Nutr. 2018 Mar 29. doi: 10.1097/MPG.0000000000001981. [Epub ahead of print] Neurodevelopmental Outcomes in Children With Liver Diseases: a Systematic Review.
Rodijk LH, den Heijer AE, Hulscher JB, Verkade HJ, de Kleine RHJ, Bruggink JLM.

Abstract

OBJECTIVE:
The aim of the study was to determine the neurodevelopmental outcomes of children with liver diseases based on a systematical review of the literature.

METHOD:

Published on: 
Mar-2018

https://www.ncbi.nlm.nih.gov/pubmed/29470284 Autoimmune hepatitis
J Pediatr Gastroenterol Nutr. 2018 Feb 21. doi: 10.1097/MPG.0000000000001927. [Epub ahead of print].Singh H, Balouch F, Noble C, Lewindon P.

Abstract

OBJECTIVES:
Autoimmune liver disease (AILD) incorporates primary sclerosing cholangitis (PSC), autoimmune hepatitis (AIH), and autoimmune sclerosing cholangitis (ASC). ASC is a condition that includes overlap of AIH and PSC. We investigate changes in practice in relation to diagnosis and phenotype over 2 time periods.

METHODS:
Retrospective chart review was conducted from January 2000 to 2016. Data were divided into two 8-year cohorts, CI and C2.

RESULTS:

Published on: 
Feb-2018

https://www.ncbi.nlm.nih.gov/pubmed/29601441
J Pediatr Gastroenterol Nutr. 2018 Mar 29. doi: 10.1097/MPG.0000000000001979. [Epub ahead of print]

The Membrane-bound O-Acyltransferase7 rs641738 Variant in Pediatric Nonalcoholic Fatty Liver Disease.

Di Sessa A, Umano GR, Cirillo G, Del Prete A, Iacomino R, Marzuillo P, Giudice EMD.

Abstract

BACKGROUND:
The rs641738 polymorphism in the membrane-bound O-acyltransferase domain containing protein 7 (MBOAT7) gene has been associated with increased risk of nonalcoholic fatty liver disease (NAFLD).

OBJECTIVES:

Published on: 
Mar-2018

https://www.ncbi.nlm.nih.gov/pubmed/29470286 NAFLD

J Pediatr Gastroenterol Nutr. 2018 Feb 21. doi: 10.1097/MPG.0000000000001926. [Epub ahead of print]
Rausch JC, Lavine JE, Chalasani N, Guo X, Kwon S, Schwimmer JB, Molleston JP, Loomba R, Brunt EM, Chen YI, Goodarzi MO, Taylor KD, Yates KP, Rotter JI; NASH Clinical Research Network.

Abstract

BACKGROUND AND OBJECTIVES:

Published on: 
Feb-2018

https://www.ncbi.nlm.nih.gov/pubmed/29601997

Contemp Clin Trials. 2018 Mar 27. pii: S1551-7144(17)30601-8. doi: 10.1016/j.cct.2018.03.014. [Epub ahead of print]

Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liverdisease in adolescents with obesity: Trial design and methodology.
Dowla S, Pendergrass M, Bolding M, Gower B, Fontaine K, Ashraf A, Soleymani T, Morrison S, Goss A.

Abstract

BACKGROUND:

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disorder among children in the developed world and can progress to cirrhosis, hepatocellular carcinoma, and liver failure. No evidence-based dietary guidelines exist on the most effective diet prescription to treat NAFLD.

OBJECTIVE:

Published on: 
Mar-2018

https://www.ncbi.nlm.nih.gov/pubmed/29470290 Autoimmune hepatitis
J Pediatr Gastroenterol Nutr. 2018 Feb 21. doi: 10.1097/MPG.0000000000001930. [Epub ahead of print]
Trevizoli IC, Pinedo CS, Teles VO, Seixas RBPM , de Carvalho E.

Abstract

OBJECTIVES:
The aim of the to evaluate the effect of autoimmune hepatitis (AIH) on the quality of life of children and adolescents and to identify which variables effect health-related quality of life (HRQoL).

METHODS:
The Pediatric Quality of Life Inventory 4.0 (PedsQL 4.0) was used to evaluate HRQoL. In addition, a questionnaire was applied which included signs, symptoms, and use of medications.

RESULTS:

Published on: 
Feb-2018

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: